NCT00573456

Far Infrared Radiation Treatment for Diabetes

Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Diabetes

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 2 (actual)
• Sponsor: GAAD Medical Research Institute Inc. · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

A study to determine the use of far infrared (FIR) radiation for treatment of diabetes.

Detailed description

Diabetes mellitus is a disease in which glucose is not sufficiently metabolized. This results in high glucose levels in blood and glucose in the urine. Cells can starve because glucose is not being metabolized. Both types of diabetes can cause dangerous complications, including blindness, heart and blood vessel disease, and kidney failure. A decrease in circulation may eventually require the amputation of limbs. We are postulating that energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to enhance the immune system; thereby improving the health of the patients.

Conditions

• Diabetes Mellitus

Interventions

Type	Name	Description
RADIATION	Far Infrared Radiation	Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 minutes per session.

Timeline

• Start date: 2006-05-01
• Primary completion: 2009-02-01
• Completion: 2009-04-01
• First posted: 2007-12-14
• Last updated: 2009-08-17

Locations

1 site across 1 country: Canada